CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)
Condition: Crohn's Disease Intervention: Drug: Certolizumab Pegol Sponsor: UCB Biopharma S.P.R.L. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials